(Q54591455)

1 June 2018

title

Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. (English)

1 reference

1 June 2018

0 references

Xiu-Qing Yao

1

1 reference

1 June 2018

Xiao-Xue Zhang

2

1 reference

1 June 2018

Yang-Yang Yin

3

1 reference

1 June 2018

Bin Liu

4

1 reference

1 June 2018

Dan-Ju Luo

5

1 reference

1 June 2018

Dan Liu

6

1 reference

1 June 2018

Ning-Ning Chen

7

1 reference

1 June 2018

Zhong-Fei Ni

8

1 reference

1 June 2018

Xiong Wang

9

1 reference

1 June 2018

Qun Wang

10

1 reference

1 June 2018

Jian-Zhi Wang

11

1 reference

1 June 2018

Gong-Ping Liu

12

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 July 2011

1 reference

1 June 2018

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Biochemical Journal

1 reference

1 June 2018

volume

437

1 reference

1 June 2018

page(s)

335-344

1 reference

1 June 2018

issue

2

1 reference

1 June 2018

A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Mechanisms of tau-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Microtubule-associated protein tau in development, degeneration and protection of neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Stress-induced hyperphosphorylation of tau in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

An alternatively spliced form of glycogen synthase kinase-3beta is targeted to growing neurites and growth cones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Phosphoprotein phosphatase activities in Alzheimer disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

The involvement of glycogen synthase kinase-3 and protein phosphatase-2A in lactacystin-induced tau accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Lithium, but not valproate, induces the serine/threonine phosphatase activity of protein phosphatase 2A in the rat brain, without affecting its expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Adeno-associated virus effectively mediates conditional gene modification in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/Protein kinase B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Crystal structure of human protein tyrosine phosphatase 1B

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Inhibition of Src by direct interaction with protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

The when and how of Src regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Src kinase regulation by phosphorylation and dephosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Localization of the genes encoding the catalytic subunits of protein phosphatase 2A to human chromosome bands 5q23-->q31 and 8p12-->p11.2, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Molecular cloning of cDNAs encoding two isoforms of the catalytic subunit of protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Molecular cloning and sequence analysis of the catalytic subunit of bovine type 2A protein phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

The GSK3 hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20110347

21 January 2018

Identifiers

DOI

10.1042/BJ20110347

1 reference

1 June 2018

PubMed ID

21554241

1 reference

1 June 2018